The author states that her granddaughter suffers from a rare disease. Clinical trials often exclude patients with rare diseases, like her granddaughter. Although there are promising clinical trials, patients with rare diseases are often missed. FDA allows expanded access to treatment. Still, patients like her granddaughter remain out of clinical trials.